I recommend buying iShares Russell Top 200 Growth ETF (IWY) for a six-month holding period, leveraging its mega-cap concentration.
Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.
Hello and welcome to another edition of Free Agent! It's still not too late to break out your ugly Christmas sweaters and ...
Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...